Graham Doyle
Stock Analyst at UBS
(0.92)
# 3,976
Out of 5,020 analysts
403
Total ratings
47.3%
Success rate
-1.5%
Average return
Main Sectors:
Stocks Rated by Graham Doyle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €56.00 | €43.80 | +27.85% | 50 | Sep 17, 2026 | |
| SWX: STMN Straumann Holding AG | Upgraded: Buy | CHF 90.00 → CHF 115.00 | CHF 91.54 | +25.63% | 17 | Sep 1, 2026 | |
| LON: SN Smith & Nephew plc | Reiterated: Hold | 1,300p → 1,120p | 982p | +14.01% | 21 | Aug 25, 2026 | |
| ETR: OBCK Ottobock SE & Co. KGaA | Reiterated: Buy | €74.00 → €78.00 | €51.90 | +50.29% | 6 | Aug 24, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Buy | CHF 86.00 → CHF 83.00 | CHF 52.86 | +57.02% | 30 | Aug 14, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Downgraded: Sell | €25.00 → €22.60 | €31.20 | -27.56% | 54 | Aug 11, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 375p | 217p | +72.97% | 22 | Aug 6, 2026 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €37.00 → €36.00 | €39.68 | -9.27% | 55 | Aug 4, 2026 | |
| ETR: SHL Siemens Healthineers AG | Reiterated: Hold | €38.00 | €37.61 | +1.04% | 49 | Aug 3, 2026 | |
| AMS: PHIA Koninklijke Philips N.V. | Downgraded: Hold | €32.50 → €24.00 | €21.20 | +13.21% | 54 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $67 → $73 | $63.98 | +14.10% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 151.00 → CHF 148.00 | CHF 113.60 | +30.28% | 6 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | kr 39.00 | kr 52.05 | -25.07% | 1 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 215.00 | CHF 250.20 | -14.07% | 15 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $118.06 | n/a | 2 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12,032.00 | n/a | 5 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,795.00 | n/a | 3 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €90.00 | €45.40 | n/a | 1 | Jan 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 275.00 | CHF 349.00 | n/a | 1 | Jun 20, 2019 |
Fresenius SE & Co. KGaA
Sep 17, 2026
Reiterated: Buy
Price Target: €56.00
Current: €43.80
Upside: +27.85%
Straumann Holding AG
Sep 1, 2026
Upgraded: Buy
Price Target: CHF 90.00 → CHF 115.00
Current: CHF 91.54
Upside: +25.63%
Smith & Nephew plc
Aug 25, 2026
Reiterated: Hold
Price Target: 1,300p → 1,120p
Current: 982p
Upside: +14.01%
Ottobock SE & Co. KGaA
Aug 24, 2026
Reiterated: Buy
Price Target: €74.00 → €78.00
Current: €51.90
Upside: +50.29%
Alcon Inc.
Aug 14, 2026
Reiterated: Buy
Price Target: CHF 86.00 → CHF 83.00
Current: CHF 52.86
Upside: +57.02%
Carl Zeiss Meditec AG
Aug 11, 2026
Downgraded: Sell
Price Target: €25.00 → €22.60
Current: €31.20
Upside: -27.56%
Convatec Group PLC
Aug 6, 2026
Reiterated: Buy
Price Target: 375p
Current: 217p
Upside: +72.97%
Fresenius Medical Care AG
Aug 4, 2026
Reiterated: Sell
Price Target: €37.00 → €36.00
Current: €39.68
Upside: -9.27%
Siemens Healthineers AG
Aug 3, 2026
Reiterated: Hold
Price Target: €38.00
Current: €37.61
Upside: +1.04%
Koninklijke Philips N.V.
Aug 3, 2026
Downgraded: Hold
Price Target: €32.50 → €24.00
Current: €21.20
Upside: +13.21%
Jul 31, 2026
Rated: Hold
Price Target: $67 → $73
Current: $63.98
Upside: +14.10%
Jul 21, 2026
Reiterated: Hold
Price Target: CHF 151.00 → CHF 148.00
Current: CHF 113.60
Upside: +30.28%
May 21, 2026
Downgraded: Sell
Price Target: kr 39.00
Current: kr 52.05
Upside: -25.07%
Mar 24, 2026
Reiterated: Hold
Price Target: CHF 215.00
Current: CHF 250.20
Upside: -14.07%
Jan 25, 2022
Downgraded: Hold
Price Target: n/a
Current: $118.06
Upside: n/a
May 29, 2020
Reiterated: Buy
Price Target: n/a
Current: $12,032.00
Upside: n/a
May 28, 2020
Reiterated: Hold
Price Target: n/a
Current: $1,795.00
Upside: n/a
Jan 22, 2020
Reiterated: Buy
Price Target: €90.00
Current: €45.40
Upside: n/a
Jun 20, 2019
Downgraded: Hold
Price Target: CHF 275.00
Current: CHF 349.00
Upside: n/a